In Bahrain, the Pharmaceutical Products Regulation Department (PPR) of the National Health Regulatory Authority (NHRA) ensures the quality, safety and efficacy of pharmaceutical products, including medicines, health products, and alternative/complementary medicines.
There are several drugs prohibited in Bahrain like all types for narcotic drugs (heroin, cocaine, hashish, pills having drugs effects etc.). The Kingdom has also recalled/removed a number of medications including:
- Dioclav 1g Tablets – NPI
- All Ranitidine Containing Medicines
- Esmya 5mg Tablets – Ferring
- Gentam 80mg/ml Solution for Injection – SPIMACO
- Pure L-Carnitine 550mg Tablets – Health Aid
- Julmentin 2X 1g Tablets – Julphar
- Zydac Solution for Injection – Jamjoom
- Ranid 150mg Tablets – Tabuk
- Pharma International Company (Jordan) Products Recall
- Avalon Avocaine Spray
- ORS NEW – NPI
- Ranitidine Containing Medicines
- Soolan Syrup & Gamavate Ointment – Julphar
- Julphar Products
- Minirin Melt 60mcg Tab – Ferring
- PMS Sulfasalazine 500mg Tab – Pharmascience
- Pentasa 1g Prolonged-Release Granules – Ferring
- Sedofan Syrup – Julphar
- Clarex 500mg Tablets – SAJA
- Floxacin 500mg Film-coated Tablets – SAJA
- Simvaten 40mg Film-coated Tablets – SAJA
- Amopress 5mg Capsules – SAJA
- Azomax 250mg Capsules – SAJA
- Omeprex 20mg Capsules – SAJA
- Profinal 100mg/5mL Suspension – Julphar
- Cefuzime 500mg Tablets – Julphar
- Zordyl Mouthwash – Julphar
- Juspirin 81mg Tablets – Julphar